Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01708161
Title A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis|Novartis Pharmaceuticals|Amgen
Indications

Advanced Solid Tumor

Therapies

Alpelisib + Ganitumab

Age Groups: adult
Covered Countries USA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Los Angeles California 90095 United States Details
Novartis Investigative Site Boston Massachusetts 02114 United States Details
Novartis Investigative Site New York New York 10017 United States Details
Novartis Investigative Site Nashville Tennessee 37203 United States Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28033 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field